Poly(ester amide)-based drug delivery systems with controlled release rate and morphology
First Claim
Patent Images
1. A medical device comprising a coating formed according to a method which comprises:
- providing a coating composition comprising a polymer and a solvent of the polymer,applying the coating composition onto the medical device,inducing phase inversion in the coating composition, andcausing the coating composition to form a layer of the coating on the medical device,wherein the coating has a morphology for controlling the release of an agent from the coating,wherein the polymer comprises a poly(ester amide) selected from the group consisting of PEA-TEMPO, PEA-Benzyl, a poly(ester amide) of 0.5 L-Leucine (cyclohexanediol) 0.5 L-Leucine (hexanediol) sebacinate, and a poly(ester amide) of phenyl alainine (propanediol) sebacinate.
0 Assignments
0 Petitions
Accused Products
Abstract
A method of forming a coating on a medical device having a controlled morphology is described. A medical device having a controlled morphology is described.
87 Citations
31 Claims
-
1. A medical device comprising a coating formed according to a method which comprises:
-
providing a coating composition comprising a polymer and a solvent of the polymer, applying the coating composition onto the medical device, inducing phase inversion in the coating composition, and causing the coating composition to form a layer of the coating on the medical device, wherein the coating has a morphology for controlling the release of an agent from the coating, wherein the polymer comprises a poly(ester amide) selected from the group consisting of PEA-TEMPO, PEA-Benzyl, a poly(ester amide) of 0.5 L-Leucine (cyclohexanediol) 0.5 L-Leucine (hexanediol) sebacinate, and a poly(ester amide) of phenyl alainine (propanediol) sebacinate. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)
-
Specification